XORTX Therapeutics (XRTX) Stock: Buy, Sell, or Hold?
XRTX - XORTX Therapeutics Inc. Common Stock
$2.33
0.22 (10.43%)
▲
5d:
+8.37%
30d:
+7.82%
90d:
+6.88%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When XRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XRTX shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XRTX shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.78
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XRTX is currently trading at $2.33, which is considered extended relative to its 30-day fair value range of $2.06 to $2.30. From a valuation perspective, the stock is trading at a premium (Forward PE: 2.1) compared to its historical average (1.8). At these levels, the market is pricing in 6.6% annual earnings growth.
Technical Outlook: Technically, XRTX is in a downtrend. Immediate support is located at $2.11, while resistance sits at $2.48. The stock is showing strong short-term momentum, up 10.4% recently.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.04 (+502.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XRTX is in a downtrend. Immediate support is located at $2.11, while resistance sits at $2.48. The stock is showing strong short-term momentum, up 10.4% recently.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $14.04 (+502.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.06 -
$2.30
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
54.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: Strong upward momentum (+10.4%)
- BULLISH: Trading 502.4% below Wall St target ($14.04)
- BULLISH: Expecting earnings turnaround to 6.6% growth with None% revenue growth
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.06 -
$2.30
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$2.48
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.12
Wall Street Target
$14.04
(+502.4%)
Earnings Growth (YoY)
-97.2%
Valuation Premium vs History
+6.6% premium
PE vs Historical
2.1 vs 1.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.6%
(market-implied from PE analysis)
1-Year Target
$2.48
(+7%)
2-Year Target
$2.65
(+14%)
3-Year Target
$2.82
(+21%)
3-Yr Target (if PE normalizes)
(PE: 2→2)
PE COMPRESSION
$2.40
(+3%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 13, 2026 8:08 PM ET
Data refreshes hourly during market hours. Next update: 9:08 PM
Data refreshes hourly during market hours. Next update: 9:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
|
LRMR
Larimar Therapeutics Inc |
STRONG BUY
11 analysts |
$14 | 58 HOLD |
